Mass production of small molecules and chemicals. Without scorching the planet.

This is a paradigm shift

Chemicals are everywhere around us. They're in our medicine, fuel, plastic, food, and most colors, to name a few applications. Biochemical extraction is often inefficient, and petrochemical production is toxic and polluting. However - for the first time in history – we now have the tools and insight to control and optimize nature’s own biological processes, enabling us to replace traditional chemical production methods with a sustainable and eco-friendly alternative: Exozymes.

From affordable feedstock to high-value chemicals

Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells. Exozyme biosolutions allow us to efficiently transform affordable and widely available feedstocks into a diverse range of valuable small-molecule chemicals, including active pharmaceutical ingredients, nutraceuticals, and biofuel.

Enzymes x AI = exozymes

Building on more than a decade of expertise in enzyme and exozyme optimization, we leverage artificial intelligence, high-quality enzyme data generation, and rational design optimization in our state-of-the-art lab to design, test, and commercially scale biosolutions. Inspired by insights from the four recent Nobel Prizes in Chemistry, our technological platform represents the pinnacle of biomanufacturing innovation.

The logical successor to SynBio

By freeing enzyme-driven chemical reactions from the limitations imposed by cellular environments, we are eliminating the scaling bottleneck that has hampered commercial success in the synthetic biology (SynBio) space - making exozyme biosolutions the logical successor to most SynBio projects.

Ensuring a green future

While petrochemicals have brought us much of the prosperity of today - we can for the first time start using nature's own inherently sustainable processes to mass produce chemicals in new and environment-friendly ways, ensuring a cleaner and greener future.

Why is it important?

Our CEO, Michael Heltzen, from the Nasdaq floor:
Exozymes allow us to live the good life with enough clean,
natural resources for everyone. Our future is bright!

current pipeline

The projects we currently have in our pipeline

NCT: Over-the-Counter

A rare natural product that activates the cell’s master metabolic control switch - finally available at scale. NCT opens a new category in metabolic wellness by addressing cellular energy efficiency rather than symptoms.

Read more

NCT: Pharma

A first-in-class approach to treating multiple metabolic diseases through a single upstream mechanism. Platform-enabled analogs of NCT unlock a previously inaccessible pharmaceutical pathway with clear acquisition relevance.

Read more

Non-intoxicating Cannabinoids

Novel, non-intoxicating molecules inspired by cannabinoid biology but unconstrained by traditional chemistry. The platform enables rapid exploration of new chemical space with multiple therapeutic and commercial pathways.

Read more

Santalene

A high-value fragrance molecule constrained by scarcity and unsustainable extraction. Cell-free production transforms santalene into a predictable, scalable ingredient while opening access to adjacent aromatic compounds.

Read more

What's the potential impact of exozymes?

Listen to the CEO of eXoZymes, Michael Heltzen, talking about the vision behind our company and how he thinks our core technology has the potential to have more global impact than the invention of something that we use every day, all day.

Subscribe

Subscribe to news

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.